| CTRI Number |
CTRI/2026/03/105664 [Registered on: 09/03/2026] Trial Registered Prospectively |
| Last Modified On: |
06/03/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device Diagnostic Screening |
| Study Design |
Other |
|
Public Title of Study
|
A Study on How Artificial Intelligence Can Help Doctors Identify Voice Box Diseases Earlier. |
|
Scientific Title of Study
|
Strategic Implementation of Artificial Intelligence in Diagnosing Laryngeal Diseases |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Neha Chaudhary |
| Designation |
|
| Affiliation |
GSVM MEDICAL COLLEGE KANPUR |
| Address |
Department of Otorhinolaryngology
Ganesh Shankar Vidyarthi Memorial Medical College
ENT Department
Lala Lajpat Rai Hospital Campus
Kanpur, Uttar Pradesh, India
Kanpur Nagar UTTAR PRADESH 208002 India |
| Phone |
8077785858 |
| Fax |
|
| Email |
cneha620@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Neha Chaudhary |
| Designation |
Junior resident |
| Affiliation |
GSVM MEDICAL COLLEGE KANPUR |
| Address |
GSVM MEDICAL COLLEGE KANPUR
Kanpur Nagar UTTAR PRADESH 208002 India |
| Phone |
8077785858 |
| Fax |
|
| Email |
cneha620@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Neha Chaudhary |
| Designation |
|
| Affiliation |
GSVM MEDICAL COLLEGE KANPUR |
| Address |
Department of Otorhinolaryngology
Ganesh Shankar Vidyarthi Memorial Medical College
ENT Department
Lala Lajpat Rai Hospital Campus
Kanpur, Uttar Pradesh, India
Kanpur Nagar UTTAR PRADESH 208002 India |
| Phone |
8077785858 |
| Fax |
|
| Email |
cneha620@gmail.com |
|
|
Source of Monetary or Material Support
|
| ICMR-MD/MS THESIS SUPPORT PROGRAM Department of health ministry New Delhi India |
|
|
Primary Sponsor
|
| Name |
Neha Chaudhary |
| Address |
GSVM MEDICAL COLLEGE KANPUR Uttar Pradesh India |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Abhishek Kesarwani |
Manipal University Jaipur |
| NIL |
NIL |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Neha Chaudhary |
GSVM MEDICAL COLLEGE Kanpur |
Department of otorhinolaryngology Gsvm medical college kanpur Kanpur Nagar UTTAR PRADESH |
8077785858
cneha620@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics committee (for biomedical and research purpose)GSVM MEDICAL COLLEGE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: D498||Neoplasm of unspecified behavior of other specified sites, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Comparing benign and malignant laryngeal disorders. |
The voice samples of patients with benign and malignant laryngeal lesions will be compared by the AI tool
Compared every 4 weeks |
| Intervention |
Diagnostic intervention |
Artificial intelligence tool which will analyse voice samples of patients.
Duration 22 months |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Voice change due to laryngeal diseases |
|
| ExclusionCriteria |
| Details |
Voice change due to rhinological cause
Cleft lip and palate
Clinical and radiological lungi abnormalities
Psychogenic abnormalities
Voice change due to central nervous system causes
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Asses the accuracy of Artificial intelligence tool in differentiating benign from malignant laryngeal disease |
Asses the accuracy of Artificial intelligence tool in differentiating benign from malignant laryngeal disease |
|
|
Secondary Outcome
|
|
|
Target Sample Size
|
Total Sample Size="150" Sample Size from India="150"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
13/04/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response (Others) - Voice
- For how long will this data be available start date provided 01-07-2024 and end date provided 09-10-2026?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
Study Objectives
Primary Objective
To evaluate the role of Artificial Intelligence in assisting the diagnosis of laryngeal diseases using laryngeal imaging.
Secondary Objectives
- To compare the diagnostic accuracy of Artificial Intelligence with clinical assessment by ENT specialists.
- To assess the ability of Artificial Intelligence to differentiate between normal, benign, and malignant laryngeal lesions.
- To determine whether Artificial Intelligence can support early detection of laryngeal diseases.
2. Inclusion Criteria
- Patients presenting with symptoms suggestive of laryngeal disease such as hoarseness of voice, throat discomfort, or voice change.
- Patients undergoing laryngeal examination using laryngoscopy or videostroboscopy in the ENT department.
- Patients aged 18 years and above.
- Patients who are willing to participate and provide informed consent.
3. Exclusion Criteria
- Patients who do not provide consent to participate in the study.
- Patients with incomplete clinical or imaging data.
- Patients with previous laryngeal surgery that significantly alters normal anatomy.
- Poor quality laryngeal images that cannot be analyzed by the Artificial Intelligence system.
4. Primary Outcome Measure
Accuracy of Artificial Intelligence in diagnosing laryngeal diseases based on analysis of laryngeal imaging.
5. Secondary Outcome Measures
- Sensitivity and specificity of Artificial Intelligence in detecting laryngeal lesions.
- Ability of Artificial Intelligence to classify lesions as normal, benign, or malignant.
- Agreement between Artificial Intelligence diagnosis and clinical diagnosis by ENT specialists.
|